Cargando…

Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells

BACKGROUND: The tumour microenvironment is a critical regulator of malignant cancer progression. While endothelial cells have been widely studied in the context of tumour angiogenesis, their role as modulators of cancer cell invasion and migration is poorly understood. METHODS: We have investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraro, Daniela A., Patella, Francesca, Zanivan, Sara, Donato, Cinzia, Aceto, Nicola, Giannotta, Monica, Dejana, Elisabetta, Diepenbruck, Maren, Christofori, Gerhard, Buess, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449935/
https://www.ncbi.nlm.nih.gov/pubmed/30947697
http://dx.doi.org/10.1186/s12885-019-5521-8
_version_ 1783408952608817152
author Ferraro, Daniela A.
Patella, Francesca
Zanivan, Sara
Donato, Cinzia
Aceto, Nicola
Giannotta, Monica
Dejana, Elisabetta
Diepenbruck, Maren
Christofori, Gerhard
Buess, Martin
author_facet Ferraro, Daniela A.
Patella, Francesca
Zanivan, Sara
Donato, Cinzia
Aceto, Nicola
Giannotta, Monica
Dejana, Elisabetta
Diepenbruck, Maren
Christofori, Gerhard
Buess, Martin
author_sort Ferraro, Daniela A.
collection PubMed
description BACKGROUND: The tumour microenvironment is a critical regulator of malignant cancer progression. While endothelial cells have been widely studied in the context of tumour angiogenesis, their role as modulators of cancer cell invasion and migration is poorly understood. METHODS: We have investigated the influence of endothelial cells on the invasive and migratory behaviour of human cancer cells in vitro. RESULTS: Upon exposure to culture supernatants of endothelial cells, distinct cancer cells, such as SK-BR-3 cells, showed significantly increased invasion and cell migration concomitant with changes in cell morphology and gene expression reminiscent of an epithelial-mesenchymal transition (EMT). Interestingly, the pro-migratory effect on SK-BR-3 cells was significantly enhanced by supernatants obtained from subconfluent, proliferative endothelial cells rather than from confluent, quiescent endothelial cells. Systematically comparing the supernatants of subconfluent and confluent endothelial cells by quantitative MS proteomics revealed eight candidate proteins that were secreted at significantly higher levels by confluent endothelial cells representing potential inhibitors of cancer cell migration. Among these proteins, nidogen-1 was exclusively expressed in confluent endothelial cells and was found to be necessary and sufficient for the inhibition of SK-BR-3 cell migration. Indeed, SK-BR-3 cells exposed to nidogen-1-depleted endothelial supernatants showed increased promigratory STAT3 phosphorylation along with increased cell migration. This reflects the situation of enhanced SK-BR-3 migration upon stimulation with conditioned medium from subconfluent endothelial cells with inherent absence of nidogen-1 expression. CONCLUSION: The identification of nidogen-1 as an endothelial-derived inhibitor of migration of distinct cancer cell types reveals a novel mechanism of endothelial control over cancer progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5521-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6449935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64499352019-04-15 Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells Ferraro, Daniela A. Patella, Francesca Zanivan, Sara Donato, Cinzia Aceto, Nicola Giannotta, Monica Dejana, Elisabetta Diepenbruck, Maren Christofori, Gerhard Buess, Martin BMC Cancer Research Article BACKGROUND: The tumour microenvironment is a critical regulator of malignant cancer progression. While endothelial cells have been widely studied in the context of tumour angiogenesis, their role as modulators of cancer cell invasion and migration is poorly understood. METHODS: We have investigated the influence of endothelial cells on the invasive and migratory behaviour of human cancer cells in vitro. RESULTS: Upon exposure to culture supernatants of endothelial cells, distinct cancer cells, such as SK-BR-3 cells, showed significantly increased invasion and cell migration concomitant with changes in cell morphology and gene expression reminiscent of an epithelial-mesenchymal transition (EMT). Interestingly, the pro-migratory effect on SK-BR-3 cells was significantly enhanced by supernatants obtained from subconfluent, proliferative endothelial cells rather than from confluent, quiescent endothelial cells. Systematically comparing the supernatants of subconfluent and confluent endothelial cells by quantitative MS proteomics revealed eight candidate proteins that were secreted at significantly higher levels by confluent endothelial cells representing potential inhibitors of cancer cell migration. Among these proteins, nidogen-1 was exclusively expressed in confluent endothelial cells and was found to be necessary and sufficient for the inhibition of SK-BR-3 cell migration. Indeed, SK-BR-3 cells exposed to nidogen-1-depleted endothelial supernatants showed increased promigratory STAT3 phosphorylation along with increased cell migration. This reflects the situation of enhanced SK-BR-3 migration upon stimulation with conditioned medium from subconfluent endothelial cells with inherent absence of nidogen-1 expression. CONCLUSION: The identification of nidogen-1 as an endothelial-derived inhibitor of migration of distinct cancer cell types reveals a novel mechanism of endothelial control over cancer progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5521-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-04 /pmc/articles/PMC6449935/ /pubmed/30947697 http://dx.doi.org/10.1186/s12885-019-5521-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ferraro, Daniela A.
Patella, Francesca
Zanivan, Sara
Donato, Cinzia
Aceto, Nicola
Giannotta, Monica
Dejana, Elisabetta
Diepenbruck, Maren
Christofori, Gerhard
Buess, Martin
Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title_full Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title_fullStr Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title_full_unstemmed Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title_short Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells
title_sort endothelial cell-derived nidogen-1 inhibits migration of sk-br-3 breast cancer cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449935/
https://www.ncbi.nlm.nih.gov/pubmed/30947697
http://dx.doi.org/10.1186/s12885-019-5521-8
work_keys_str_mv AT ferrarodanielaa endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT patellafrancesca endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT zanivansara endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT donatocinzia endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT acetonicola endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT giannottamonica endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT dejanaelisabetta endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT diepenbruckmaren endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT christoforigerhard endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells
AT buessmartin endothelialcellderivednidogen1inhibitsmigrationofskbr3breastcancercells